# YAP1 reactivation in cardiomyocytes following ECM remodelling contributes to the development of contractile force and sarcomere maturation

**Authors:** Vladimir Vinarsky, Stefania Pagliari, Bacel Aldabash, Fabiana Martino, Cristina Mazzotti, Katerina Jirakova, Zuzana Garlikova, Enrico Di Iuri, Daniel Kytyr, Patrizia Benzoni, Martina Arici, Alessia Metallo, Kira Zeevaert, Wolfgang Wagner, Marcella Rocchetti, Giancarlo Forte

PMC · DOI: 10.1038/s41420-025-02793-2 · Cell Death Discovery · 2025-11-10

## TL;DR

YAP1 activation in heart cells after ECM changes helps develop muscle strength and maturation.

## Contribution

This study reveals how YAP1 reactivation contributes to cardiomyocyte maturation and contractility through ECM remodelling.

## Key findings

- YAP1 nuclear shuttling promotes cardiomyocyte maturation and myofibril alignment.
- YAP1 deficiency reduces contractile force development in engineered heart tissues.
- ECM remodelling activates YAP1 to enhance sarcomere maturation and electrophysiological properties.

## Abstract

Cardiac diseases are fueled by extracellular matrix (ECM) remodelling. Together with the altered ECM chemical composition, the mechanical turmoil associated with ECM maladaptive remodelling in the pathological heart drives the shuttling of Yes Associated Protein 1 (YAP1) into cardiomyocyte (CM) nuclei that results either in cell cycle re-entry or cardiomyocyte hypertrophy. The mechanism of YAP1 reactivation and factors driving qualitatively different cellular outcomes is not well understood. Here we employed mechanical actuation as a proxy reproducing ECM remodelling in vitro to trigger YAP1 nuclear shuttling in contractile cardiomyocytes derived from human embryonic and induced pluripotent stem cells (hPSCs). By using hPSC lines in which YAP1 expression has been genetically depleted, super-resolution microscopy and electrophysiological measurements, we show that ECM-triggered nuclear presence of endogenous YAP1 contributes to cardiomyocyte maturation, participates in the formation and alignment of myofibrils, as well as in the maturation of their electrophysiological properties and calcium dynamics. We eventually exploit engineered heart tissues (EHTs) to demonstrate that the net effect of YAP1 deficiency in cardiomyocytes is the inability to respond to physiological stimuli by compensatory growth that results in reduced force development. These results suggest that the re-activation of endogenous YAP1 following ECM maladaptive remodelling promotes cardiomyocyte contractility by restructuring the sarcomere apparatus and the maturation of electrophysiological properties via transcriptionally dependent and independent mechanisms.

## Linked entities

- **Genes:** YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}
- **Diseases:** Cardiac diseases (MESH:D006331), cardiomyocyte hypertrophy (MESH:D006984)
- **Chemicals:** calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12603042/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12603042/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12603042/full.md

---
Source: https://tomesphere.com/paper/PMC12603042